G1 Therapeutics, Inc. Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. for December 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2017 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 181,933 | |
| Dec 20 2017 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 20.01 | 7,500 | 150,106 | 0 | 7.5 K to 0 (-100.00 %) |
| Dec 20 2017 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| Dec 18 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Sell | S | 19.75 | 200,000 | 3,950,000 | 2,950,630 | 3.2 M to 3 M (-6.35 %) |
| Dec 06 2017 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Option Exercise | A | 19.46 | 250,000 | 4,865,000 | 250,000 | |
| Dec 05 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Sell | S | 19.75 | 133,906 | 2,644,644 | 3,150,630 | 3.3 M to 3.2 M (-4.08 %) |
| Dec 04 2017 | GTHX | G1 Therapeutics, I ... | SHAFFER CHRISTY L | Director | Buy | J | 0.00 | 995 | 0 | 995 | 0 to 995 |
| Dec 04 2017 | GTHX | G1 Therapeutics, I ... | SHAFFER CHRISTY L | Director | Sell | J | 0.00 | 99,513 | 0 | 0 | 99.5 K to 0 (-100.00 %) |
| Dec 04 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | J | 0.00 | 995 | 0 | 4,075,211 | 4.1 M to 4.1 M (+0.02 %) |
| Dec 04 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | J | 0.00 | 99,513 | 0 | 4,074,216 | 4.2 M to 4.1 M (-2.38 %) |